U.S. Secures 3.2 Million Novavax Covid Vaccines — Offering Alternative To MRNA Shots As New Variant SpreadsForbes • 07/11/22
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still PendingBenzinga • 07/11/22
Novavax stock rallies after EU expands CMA on COVID vaccine for 12 to 17-year oldsMarket Watch • 07/05/22
Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17PRNewsWire • 07/05/22
Novavax is part of the FDA's COVID-19 booster debate, but its vaccine still hasn't been authorizedMarket Watch • 06/29/22
Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific VariantsPRNewsWire • 06/28/22